Resistell Ag

Resistell develops a diagnostic platform for ultra-rapid phenotypic antibiotic susceptibility testing (AST) using nanomotion technology. The system measures the vibrations of living bacterial cells to determine effective antibiotic treatments in approximately one hour, bypassing the need for traditional growth-based cultures. The technology is designed for healthcare providers and clinical laboratories to combat antimicrobial resistance and optimize patient therapy for infections such as bacteremia and tuberculosis.